Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/12 → 8/30/14 |
Funding
- Vertex Pharmaceuticals Inc: $2,630.00
VX12-770-112 / A Phase 3, Two-Arm, Rollover Study to Evaluate the Safety of Long-Term Ivacaftor Treatment in Subjects 6 Years of Age and Older
- Anstead, Michael (PI)
- Danov, Zoran (CoI)
- Kanga, Jamshed (CoI)